financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Intel Corp.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Intel Corp.
Sep 20, 2025 8:13 AM

10:00 AM EDT, 09/18/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We up our 12-month target to $35 from $24, on a higher revised P/E of 24x our 2027 EPS estimate, well above historical/peers. NVDA announced a $5B investment stake in INTC (purchased at $23.28) and greater collaboration whereby the two will co-develop products together. On the data center front, NVLink will integrate NVDA's Arm-based GPUs and INTC's x86 ecosystem. On PCs, INTC will integrate NVDA's RTX GPUs with its x86 CPUs. Timing of product releases remains to be seen, but on the surface, the NVDA investment should be viewed as a vote of confidence for INTC investors. The expanded partnership is solely for products, which has completely missed the AI boat, and we question whether this will significantly improve INTC's data center prospects (NVDA will still push its Arm-based CPU offerings) and drive earnings upside. That said, we do believe it does set up the prospects for NVDA to eventually leverage INTC's foundry business as INTC desperately seeks a major external partner. We would avoid chasing shares.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Allegiant Travel Company
Research Alert: CFRA Keeps Hold Opinion On Shares Of Allegiant Travel Company
May 7, 2024
01:00 AM EDT, 05/08/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $16 to $60, 10.3x our 2025 EPS estimate (cut by $1.31 to $5.80; 2024's cut by $3.60 to $3.20), a discount to ALGT's five-year...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Lumentum Holdings Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Lumentum Holdings Inc.
May 7, 2024
12:40 AM EDT, 05/08/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target price by $5 to $50, 27.3x our FY 25 (Jun.) EPS estimate, a discount to its 10-year historical average P/E of 38.2x, reflecting our slower...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Expeditors International Of Washington
Research Alert: CFRA Keeps Sell Opinion On Shares Of Expeditors International Of Washington
May 7, 2024
12:15 AM EDT, 05/08/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $104, cut by $2, reflects a 21x multiple of projected '25 EPS, in line with EXPD's historical forward average. We lift our '24 EPS estimate...
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
May 7, 2024
12:30 AM EDT, 05/08/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of $17, implying 11.7x our 2024 earnings per ADS, below its 3-year mean of 14.5x, justified in our view to reflect the long-term growth uncertainty....
Copyright 2023-2026 - www.financetom.com All Rights Reserved